Gelteq Limited (GELS)
NASDAQ: GELS · Real-Time Price · USD
2.590
-0.130 (-4.78%)
Dec 20, 2024, 4:00 PM EST - Market closed

Gelteq Revenue

In the fiscal year ending June 30, 2024, Gelteq had annual revenue of 143.31K AUD, down -58.21%. Gelteq had revenue of 31.90K in the quarter ending June 30, 2024.

Revenue (ttm)
143.31K AUD
Revenue Growth
-61.48%
P/S Ratio
219.90
Revenue / Employee
17,914 AUD
Employees
8
Market Cap
24.44M USD

Revenue Chart

* This company reports financials in AUD.

History

Fiscal Year End Revenue Change Growth
Jun 30, 2024143.31K-199.59K-58.21%
Jun 30, 2023342.90K-29.17K-7.84%
Jun 30, 2022372.07K212.20K132.73%
Jun 30, 2021159.87K--
Jun 30, 2020---
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
HOOKIPA Pharma 50.00M
Vivos Therapeutics 14.58M
Daré Bioscience 1.88M
Longeveron 1.85M
Femasys 1.26M
Adagio Medical Holdings 543.00K
Revenue Rankings